Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples